Peapack Gladstone Financial Corp Novartis Ag Transaction History

Peapack Gladstone Financial Corp

$6.94 Billion
Q3 2024

A detailed history of Peapack Gladstone Financial Corp transactions in Novartis Ag stock. As of the latest transaction made, Peapack Gladstone Financial Corp holds 25,157 shares of NVS stock, worth $2.48 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

25,157

Previous 25,118 0.16%

Holding current value

$2.48 Million

Previous $2.67 Million 8.31%

% of portfolio

0.04%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 26, 2024	BUY	$106.13 - $120.89 $4,139 - $4,714	39 Added 0.16%	25,157 $2.9 Million
Q2 2024 Aug 13, 2024	SELL	$92.57 - $107.37 $41,749 - $48,423	-451 Reduced 1.76%	25,118 $2.67 Million
Q1 2024 May 10, 2024	SELL	$95.27 - $108.47 $88,124 - $100,334	-925 Reduced 3.49%	25,569 $2.47 Million
Q4 2023 Feb 13, 2024	SELL	$92.27 - $101.54 $100,112 - $110,170	-1,085 Reduced 3.93%	26,494 $2.67 Million
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $57,880 - $64,234	-611 Reduced 2.17%	27,579 $2.81 Million
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $2,127 - $2,412	-23 Reduced 0.08%	28,190 $2.84 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $2.82 Million - $3.28 Million	-35,291 Reduced 55.57%	28,213 $2.59 Million
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $146,189 - $179,026	-1,935 Reduced 2.96%	63,504 $5.76 Million
Q3 2022 Nov 10, 2022	BUY	$74.61 - $87.26 $213,832 - $250,087	2,866 Added 4.58%	65,439 $4.97 Million
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $91,953 - $107,062	-1,142 Reduced 1.79%	62,573 $5.29 Million
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $957,074 - $1.08 Million	-11,947 Reduced 15.79%	63,715 $5.59 Million
Q4 2021 Feb 15, 2022	BUY	$79.7 - $88.13 $4,303 - $4,759	54 Added 0.07%	75,662 $6.62 Million
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $8,750 - $10,179	-107 Reduced 0.14%	75,608 $6.18 Million
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $131,184 - $144,896	-1,539 Reduced 1.99%	75,715 $6.91 Million
Q1 2021 May 14, 2021	SELL	$83.5 - $98.47 $46,175 - $54,453	-553 Reduced 0.71%	77,254 $6.6 Million
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $1.83 Million - $2.21 Million	-23,420 Reduced 23.14%	77,807 $7.35 Million
Q3 2020 Nov 16, 2020	BUY	$82.14 - $91.0 $85,507 - $94,731	1,041 Added 1.04%	101,227 $8.8 Million
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $940,568 - $1.06 Million	11,622 Added 13.12%	100,186 $8.75 Million
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $2.43 Million - $3.4 Million	34,352 Added 63.37%	88,564 $7.3 Million
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $35,595 - $40,246	422 Added 0.78%	54,212 $5.13 Million
Q3 2019 Nov 13, 2019	SELL	$85.54 - $94.26 $11,547 - $12,725	-135 Reduced 0.25%	53,790 $4.67 Million
Q2 2019 Aug 15, 2019	SELL	$75.4 - $92.8 $78,265 - $96,326	-1,038 Reduced 1.89%	53,925 $4.92 Million
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $2,560 - $2,929	34 Added 0.06%	54,963 $5.29 Million
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $2.84 Million - $3.16 Million	38,564 Added 235.65%	54,929 $4.71 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $174,378 - $201,705	2,605 Added 18.93%	16,365 $1.41 Million
Q2 2018 Aug 09, 2018	SELL	$64.91 - $73.36 $3,634 - $4,108	-56 Reduced 0.41%	13,760 $1.04 Million
Q1 2018 May 10, 2018	SELL	$70.39 - $84.15 $108,963 - $130,264	-1,548 Reduced 10.08%	13,816 $0
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $44,121 - $47,360	610 Added 4.13%	15,364 $0
Q3 2017 Nov 14, 2017	SELL	$74.14 - $77.27 $38,997 - $40,644	-526 Reduced 3.44%	14,754 $0
Q2 2017 Aug 14, 2017	BUY	N/A	15,280	15,280 $0

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Peapack Gladstone Financial Corp with notifications on news.

Account

Peapack Gladstone Financial Corp Novartis Ag Transaction History